Abstract

The Global Advisory Committee on Vaccine Safety (GACVS), an independent expert clinical and scientific advisory body, provides WHO with scientifically rigorous advice on vaccine safety issues of potential global importance.

GACVS held its 33rd meeting in Geneva, Switzerland, on 2–3 December 2015.

The Committee examined the clinical and population characteristics of cluster immunization anxiety-related reactions and the detection of vaccine safety signals from spontaneous reporting databases. It also reviewed vaccine-specific safety issues concerning RTS,S malaria vaccine, safety of human papillomavirus (HPV) vaccines, pandemic influenza vaccine and narcolepsy, and the safety profile of smallpox vaccines.

  • GAVCS